Table 5.
Mutants selected from libraries (see Table 3) | Corresponding site-directed mutantsb | ||||||||||||||||||
Light-chain CDR3 sequence | Light-chain CDR3 sequence | ||||||||||||||||||
Fab | 91 | a | b | 92 | 93 | 94 | 95 | 96 | IC50 ratioa digitoxin/ digoxin | Fab | 91 | a | b | 92 | 93 | 94 | 95 | 96 | IC50 ratioc digitoxin/ digoxin |
26-10 wt | T | T | H | V | P | P | 3 | 26-10:V94W | T | T | H | W | P | P | 0.25 | ||||
IDGW7 | T | N | P | R | L | F | P | P | 0.5 | IDGW7:F94W | T | N | P | R | L | W | P | P | 0.12 |
IDGW12 | T | A | P | V | L | F | P | P | 1 | IDGW12:P91bA | T | A | A | V | L | F | P | P | 1 |
IDGW14 | T | T | P | R | A | W | P | P | 0.06 | IDGW14:W94F | T | T | P | R | A | F | P | P | 2.25 |
IDGW15 | T | L | F | W | P | P | 0.18 | IDGW15:W94F | T | L | F | F | P | P | 1 |
a These mutants are among those listed in Table 2, and were obtained following panning on digitoxin–BSA.
b Mutants are defined using the one-letter code by the residue in the parent, followed by the light-chain position number, followed by the resultant mutant residue. The positions for site-directed mutagenesis are given in bold-face type.
c Values reported are ratios of molar concentration of inhibitor required to give 50% inhibition of Fab binding to analog–BSA-coated wells, relative to the respective molar concentrations of digoxin.